Adrenomedullin blockade suppresses growth of human hormone-independent prostate tumor xenograft in mice

Clinical Cancer Research

Volumn 19, Issue 22, 2013, Pages 6138-6150

  Berenguer Daize, Caroline ^a,b   Boudouresque, Francoise ^a,b   Bastide, Cyrille ^c   Tounsi, Asma ^a,b   Benyahia, Zohra ^a,b   Acunzo, Julie ^a,b   Dussault, Nadege ^a,b   Delfino, Christine ^a,b   Baeza, Nathalie ^a,b   Daniel, Laurent ^a,b   Cayol, Mylene ^a,b   Rossi, Dominique ^c   El Battari, Assou ^a,b   Bertin, Denis ^a   Mabrouk, Kamel ^a   Martin, Pierre Marie ^a,b,c   Ouafik, L'Houcine ^a,b,c  

^a AIX MARSEILLE UNIVERSITY   (France)

^b INSERM   (France)

^c HÔPITAL NORD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENOMEDULLIN; ADRENOMEDULLIN ANTIBODY; ADRENOMEDULLIN RECEPTOR; CYCLIC AMP; IMMUNOGLOBULIN G; MITOGEN ACTIVATED PROTEIN KINASE; PLACEBO; POLYCLONAL ANTIBODY; RAF PROTEIN; UNCLASSIFIED DRUG;

ABLATION THERAPY; ANDROGEN DEPENDENT PROSTATE CANCER; ANDROGEN INDEPENDENT PROSTATE CANCER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; AUTOCRINE EFFECT; CANCER CELL CULTURE; CANCER GRADING; CANCER GROWTH; CANCER INHIBITION; CASTRATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG PROTEIN BINDING; DRUG TARGETING; EXPERIMENTAL MOUSE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LYMPHANGIOGENESIS; MALE; MOUSE; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; TUMOR VASCULARIZATION; TUMOR XENOGRAFT;

ADRENOMEDULLIN; ANDROGENS; ANIMALS; ANTIBODIES; APOPTOSIS; CARRIER PROTEINS; CASTRATION; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CYCLIC AMP; ENDOTHELIAL CELLS; HUMANS; LYMPHANGIOGENESIS; MALE; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; PERICYTES; PROSTATIC NEOPLASMS, CASTRATION-RESISTANT; RECEPTOR ACTIVITY-MODIFYING PROTEIN 2; RECEPTOR ACTIVITY-MODIFYING PROTEIN 3; RECEPTORS, ADRENOMEDULLIN; RECEPTORS, CALCITONIN; SIGNAL TRANSDUCTION; TRANSPLANTATION, HETEROLOGOUS;

EID: 84888123063     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-13-0691     Document Type: Article

References (50)

1. Bostwick DG. Prostatic intraepithelial neoplasia (PIN). Urology 1989;34:16-22.
2. Bostwick DG, Shan A, Qian J, Darson M, Maihle NJ, Jenkins RB, et al. Independent origin of multiple foci of prostatic intraepithelial neoplasia: comparison with matched foci of prostate carcinoma. Cancer 1998;83:1995-2002. (Pubitemid 28503732)
3. Feldman BJ, Feldman D. The development of androgen-independent prostate cancer. Nat Rev Cancer 2001;1:34-45. (Pubitemid 33741879)
4. Miller MJ, Martinez A, Unsworth EJ, Thiele CJ, Moody TW, Elsasser T, et al. Adrenomedullin expression in human tumor cell lines. Its potential role as an autocrine growth factor. J Biol Chem 1996;271:23345-51. (Pubitemid 26314779)
5. Zhao Y, Hague S, Manek S, Zhang L, Bicknell R, Rees MC. PCR display identifies tamoxifen induction of the novel angiogenic factor adrenomedullin by a non estrogenic mechanism in the human endometrium. Oncogene 1998;16:409-15. (Pubitemid 28052295)
6. Hinson JP, Kapas S, Smith DM. Adrenomedullin, a multifunctional regulatory peptide. Endocr Rev 2000;21:138-67. (Pubitemid 32275593)
7. Fernandez-Sauze S, Delfino C, Mabrouk K, Dussert C, Chinot O, Martin PM, et al. Effects of adrenomedullin on endothelial cells in the multistep process of angiogenesis: involvement of CRLR/RAMP2 and CRLR/RAMP3 receptors. Int J Cancer 2004;108:797-804. (Pubitemid 38112605)
8. McLatchie LM, Fraser NJ, Main MJ, Wise A, Brown J, Thompson N, et al. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor- like receptor. Nature 1998;393:333-9. (Pubitemid 28269699)
9. Poyner DR, Sexton PM, Marshall I, Smith DM, Quirion R, Born W, et al. International Union of Pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors. Pharmacol Rev 2002;54:233-46. (Pubitemid 34575714)
10. Zudaire E, Martinez A, Cuttitta F. Adrenomedullin and cancer. Regul Peptide 2003;112:175-83. (Pubitemid 36351615)
11. Rocchi P, Boudouresque F, Zamora AJ, Muracciole X, Lechevallier E, Martin PM, et al. Expression of adrenomedullin and peptide amidation activity in human prostate cancer and in human prostate cancer cell lines. Cancer Res 2001;61:1196-206. (Pubitemid 32174443)
12. Oehler MK, Hague S, Rees MC, Bicknell R. Adrenomedullin promotes formation of xenografted endometrial tumors by stimulation of autocrine growth and angiogenesis. Oncogene 2002;21:2815-21. (Pubitemid 34499378)
13. Ouafik L, Sauze S, Boudouresque F, Chinot O, Delfino C, Fina F, et al. Neutralization of adrenomedullin inhibits the growth of human glioblastoma cell lines in vitro and suppresses tumor xenograft growth in vivo. Am J Pathol 2002;160:1279-92. (Pubitemid 34411632)
14. Ramachandran V, Arumugam T, Hwang RF, Greenson JK, Simeone DM, Logsdon CD. Adrenomedullin is expressed in pancreatic cancer and stimulates cell proliferation and invasion in an autocrine manner via the adrenomedullin receptor, ADMR. Cancer Res 2007;67:2666-75. (Pubitemid 46548954)
15. Keleg S, Kayed H, Jiang X, Penzel R, Giese T, Buchler MW, et al. Adrenomedullin is induced by hypoxia and enhances pancreatic cancer cell invasion. Int J Cancer 2007;121:21-32. (Pubitemid 46759489)
16. Ishikawa T, Chen J, Wang J, Okada F, Sugiyama T, Kobayashi T, et al. Adrenomedullin antagonist suppresses in vivo growth of human pancreatic cancer cells in SCID mice by suppressing angiogenesis. Oncogene 2003;22:1238-42. (Pubitemid 36363387)
17. Kaafarani I, Fernandez-Sauze S, Berenguer C, Chinot O, Delfino C, Dussert C, et al. Targeting adrenomedullin receptors with systemic delivery of neutralizing antibodies inhibits tumor angiogenesis and suppresses growth ofhumantumor xenograftsin mice. FASEB J 2009;23:3424-35.
18. Jimenez N, Abasolo I, Jongsma J, Calvo A, Garayoa M, van der Kwast TH, et al. Androgen-independent expression of adrenomedullin and peptidylglycine alpha-amidating monooxygenase in human prostatic carcinoma. Mol Carcinog 2003;38:14-24. (Pubitemid 37122316)
19. Mazzocchi G, Malendowicz LK, Ziolkowska A, Spinazzi R, Rebuffat P, Aragona F, et al. Adrenomedullin (AM) and AM receptor type 2 expression is up-regulated in prostate carcinomas (PC), and AM stimulates in vitro growth of a PC-derived cell line by enhancing proliferation and decreasing apoptosis rates. Int J Oncol 2004;25:1781-7.
20. Joshi BH, Leland P, Calvo A, Green JE, Puri RK. Human adrenomedullin up-regulates interleukin-13 receptor alpha2 chain in prostate cancer in vitro and in vivo: a novel approach to sensitize prostate cancer to anticancer therapy. Cancer Res 2008;68:9311-7.
21. Rocchi P, Muracciole X, Fina F, Mulholland DJ, Karsenty G, Palmari J, et al. Molecular analysis integrating different pathways associated with androgen-independent progression in LuCaP 23.1 xenograft. Oncogene 2004;23:9111-9. (Pubitemid 40013078)
22. Berenguer C, Boudouresque F, Dussert C, Daniel L, Muracciole X, Grino M, et al. Adrenomedullin, an autocrine/paracrine factor induced by androgen withdrawal, stimulates 'neuroendocrine phenotype' in LNCaP prostate tumor cells. Oncogene 2008;27:506-18.
23. Deville JL, Bartoli C, Berenguer C, Fernandez-Sauze S, Kaafarani I, Delfino C, et al. Expression and role of adrenomedullin in renal tumors and value of its mRNA levels as prognostic factor in clear-cell renal carcinoma. Int J Cancer 2009;125:2307-15.
24. Portal-Nunez S, Shankavaram UT, Rao M, Datrice N, Atay S, Aparicio M, et al. Aryl hydrocarbon receptor-induced adrenomedullin mediates cigarette smoke carcinogenicity in humans and mice. Cancer Res 2012;72:5790-800.
25. Kato J, Kitamura K, Kangawa K, Eto T. Receptors for adrenomedullin in human vascular endothelial cells. Eur J Pharmacol 1995;289:383-5.
26. Shimekake Y, Nagata K, Ohta S, Kambayashi Y, Teraoka H, Kitamura K, et al. Adrenomedullin stimulates two signal transduction pathways, cAMP accumulation and Ca2+ mobilization, in bovine aortic endothelial cells. J Biol Chem 1995;270:4412-7.
27. Ilan N, Mahooti S, Madri JA. Distinct signal transduction pathways are utilized during the tube formation and survival phases of in vitro angiogenesis. J Cell Sci 1998;111:3621-31. (Pubitemid 29017560)
28. Yu Y, Sato JD. MAP kinases, phosphatidylinositol 3-kinase, and p70 S6 kinase mediate the mitogenic response of human endothelial cells to vascular endothelial growth factor. J Cell Physiol 1999;178:235-46. (Pubitemid 29034867)
29. Bergers G, Song S, Meyer-Morose N, Bergsland E, Hanahan D. Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. J Clin Invest 2003;111:1287-95. (Pubitemid 36554699)
30. Lutter S, Xie S, Tatin F, Makinen T. Smooth-muscle-endothelial cell communication activates Reelin signaling and regulates lymphatic vessel formation. J Cell Biol 2012;197:837-49.
31. Nikitenko LL, Fox SB, Kehoe S, Rees MC, Bicknell R. Adrenomedullin and tumour angiogenesis. Br J Cancer 2006;94:1-7. (Pubitemid 43088532)
32. Nagy JA, Chang S-H, Dvorak AM, Dvorak HF. Why are tumour blood vessels abnormal and why is it important to know? Br J Cancer 2009;100:865-9.
33. Thompson VC, Day TK, Bianco-Miotto T, Selth LA, Han G, Thomas M, et al. a gene signature identified using a mouse model of androgen receptor-dependent prostate cancer predicts biochemical relapse in human disease. Int J Cancer 2012;131:662-72.
34. Stacker SA, Achen MG, Jussila L, Baldwin ME, Alitalo K. Lymphangiogenesis and cancer metastasis. Nat Rev Cancer 2002;2:573-83. (Pubitemid 37328924)
35. He Y, Kozaki K, Karpanen T, koshikawa K, Yla-Herttuala S, Takahashi T, et al. Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling. J Natl Cancer Inst 2002;94:819-25. (Pubitemid 34705053)
36. Skobe M, Hawighorst T, Jackson DG, Prevo R, Janes L, Velasco P, et al. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 2001;7:192-8. (Pubitemid 32148486)
37. Garayoa M, Martinez A, Lee S, Pio R, An WG, Neckers L, et al. Hypoxia-inducible factor-1 (HIF-1) up-regulates adrenomedullin expression in human tumor cells lines during oxygen deprivation: a possible promotion mechanism of carcinogenesis. Mol Endocrinol 2000;41:848-62. (Pubitemid 32260498)
38. Fritz-Six KL, Dunworth WP, Li M, Caron KM. Adrenomedullin signaling is necessary for murine lymphatic vascular development. J Clin Invest 2008;118:40-50.
39. Jin D, Harada K, Ohnishi S, Yamahara K, Kangawa K, Nagaya N. Adrenomedullin induces lymphangiogenesis and ameliorates secondary lymphoedema. Cardiovasc Res 2008;80:339-45.
40. Achen MG, McColl BK, Stacker SA. Focus on lymphangiogenesis in tumor metastasis. Cancer Cell 2005;7:121-7. (Pubitemid 40248338)
41. Tobler NE, Detmar M. Tumor and lymph node lymphangiogenesis-impact on cancer metastasis. J Leukoc Biol 2006;80:691-6. (Pubitemid 44835883)
42. Joyce JA, Pollard JW. Microenvironmental regulation of metastasis. Nat Rev Cancer 2009;9:239-52.
43. Alitalo K, Tammela T, Petrova TV. Lymphangiogenesis in development and human disease. Nature 2005;438:946-53. (Pubitemid 43093960)
44. Nagy JA, Vasile E, Feng D, Sundberg C, Brown LF, Detmar MJ, et al. Vascular permeability factor/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis. J Exp Med 2002;196:1497-506. (Pubitemid 35424943)
45. Hirakawa S, Kodama S, Kunstfeld R, Kajiya K, Brown LF, Detmar M. VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis. J Exp Med 2005;201:1089-99. (Pubitemid 40524677)
46. Cao R, Bjorndahl MA, Religa P, Clasper S, Garvin S, Galter D, et al. PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis. Cancer Cell 2004;6:333-45. (Pubitemid 39361435)
47. Cao Y. Opinion: emerging mechanisms of tumour lymphangiogenesis and lymphatic metastasis. Nat Rev Cancer 2005;5:735-43. (Pubitemid 41486366)
48. Karkkainen MJ, Makinen T, Alitalo K. Lymphatic endothelium: a new frontier of metastasis research. Nat Cell Biol 2002;4:E2-5. (Pubitemid 34071967)
49. Tammela T, Alitalo K. Lymphangiogenesis: molecular mechanisms and future promise. Cell 2010;140:460-76.
50. Martinez A, Julian M, Bregonzio C, Notari L, Moody TW, Cuttitta F. Identification of vasoactive nonpeptidic positive and negative modulators of adrenomedullin using a neutralizing antibody-based screening strategy. Endocrinology 2004;145:3858-65 (Pubitemid 39037574)